Advertisement

Topics

"Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study" Drugs and Medication Database

16:52 EST 20th January 2019 | BioPortfolio

Here are the most relevant "Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study" Drugs and Medications that we have found in our database.

More Information about "Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study" on BioPortfolio

We have published hundreds of Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study news stories on BioPortfolio along with dozens of Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study Clinical Trials and PubMed Articles about Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study Companies in our database. You can also find out about relevant Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study Drugs and Medications on this site too.

Showing "Supraglottic Airway Devices Severely Obese Patients Feasibility Study" Drugs and Medications 1–25 of 40

Probably Relevant

Acd [Terumo BCT Ltd]

Anticoagulant Citrate Dextrose Solution USP (ACD) Solution A

Possibly Relevant

Haemonetics anticoagulant sodium citrate [Haemonetics Corporation]

Haemonetics Anticoagulant Sodium Citrate

Haemonetics anticoagulant citrate dextrose solution [Haemonetics Corporation]

Haemonetics Anticoagulant Citrate Dextrose Solution

Anticoagulant citrate dextrose a acd-a [Arteriocyte Medical Systems, Inc.]

Anticoagulant Citrate Dextrose Solution,Solution A, USP

Oxygen [Intermountain Home Care]

Oxygen

As [Terumo BCT Ltd]

Additive Solution Formula 3

Haemonetics additive solution formula 3 (as-3) [Haemonetics Corporation]

Haemonetics

Oxygen [Alternacare Home Health Services]

NA

Medi-patch with lidocaine [Two Hip Consulting, LLC]

NA

Sodium chloride [Spectra Medical Devices, Inc.]

1.14.1.3 Draft Labeling Text

Acd [Terumo BCT, Ltd.]

These highlights do not include all the information needed to use ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A safely and effectively. See full prescribing information for ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A. ANTIC

Medi-patch with lidocaine [Two Hip Consulting, LLC]

NA

Sterile water [Hospira, Inc.]

Sterile Water for Injection, USP

Haemonetics additive solution formula 3 (as-3) [Haemonetics Corporation]

Haemonetics Additive Solution Formula 3 (AS-3)

Haemonetics anticoagulant citrate phosphate double dextrose solution (cp2d) [Haemonetics Corporation]

Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D)

Sodium chloride [Spectra Medical Devices, Inc.]

SODIUM CHLORIDE

Neostigmine methylsulfate [Amphastar Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use NEOSTIGMINE METHYLSULFATE INJECTION, USP, safely and effectively. See full prescribing information for NEOSTIGMINE METHYLSULFATE INJECTION, USP.NEOSTIGMINE METHYLSULFATE injection,for intra

Neostigmine methylsulfate [Medical Purchasing Solutions, LLC]

These highlights do not include all the information needed to use NEOSTIGMINE METHYLSULFATE INJECTION, USP, safely and effectively. See full prescribing information for NEOSTIGMINE METHYLSULFATE INJECTION, USP. NEOSTIGMINE METHYLSULFATE injection, for int

Fragmin [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use FRAGMIN safely and effectively. See full prescribing information for FRAGMIN. FRAGMIN (dalteparin sodium) injection, for subcutaneous useInitial U.S. Approval: 1994

Humira [A-S Medication Solutions]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimumab) injection, for subcutaneous useInitial U.S. Approval: 2002

Neostigmine methylsulfate [Amneal Biosciences LLC]

These highlights do not include all the information needed to use NEOSTIGMINE METHYLSULFATE INJECTION safely and effectively. See full prescribing information for NEOSTIGMINE METHYLSULFATE INJECTION. NEOSTIGMINE methylsulfate injection, for intravenous u

Humira [AbbVie Inc.]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimumab) injection, for subcutaneous useInitial U.S. Approval: 2002

Neostigmine methylsulfate [West-Ward Pharmaceuticals Corp.]

These highlights do not include all the information needed to use NEOSTIGMINE METHYLSULFATE INJECTION safely and effectively. See full prescribing information for NEOSTIGMINE METHYLSULFATE INJECTION. NEOSTIGMINE METHYLSULFATE injection, for intravenous us

Neostigmine methylsulfate [Par Pharmaceutical, Inc.]

These highlights do not include all the information needed to use Neostigmine Methylsulfate Injection safely and effectively. See full prescribing information for Neostigmine Methylsulfate Injection.NEOSTIGMINE METHYLSULFATE injection, for intravenous use

Neostigmine methylsulfate [Medical Purchasing Solutions, LLC]

These highlights do not include all the information needed to use Neostigmine Methylsulfate Injection safely and effectively. See full prescribing information for Neostigmine Methylsulfate Injection. NEOSTIGMINE METHYLSULFATE injection, for intravenous us



Advertisement
Quick Search
Advertisement
Advertisement